Please note that this page may contain information on EMD Serono, Inc. marketed and/or investigational products. Investigational agents and investigational indications for marketed products are under clinical investigation and have not been proven to be safe and effective. There is no guarantee that any product will be approved in the sought-after indication. Please click here to view the full EMD Serono pipeline.
Tuvusertib (M1774)
Tuvusertib is an ATR (ataxia telangiectasia and Rad3 related kinase) inhibitor under clinical investigation in patients with solid tumors.
Lartesertib (M4076)
Lartesertib is an ATM (ataxia telangiectasia mutated kinase) inhibitor under clinical investigation in patients with solid tumors.
M9140
M9140 is an anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) ADC under clinical investigation in patients with solid tumors.
Avelumab
Avelumab is an anti-PD-L1 antibody under clinical investigation in patients with solid tumors.
M6223
M6223 is an anti-TIGIT (T Cell Immunoreceptor With Ig And ITIM Domains) antibody under clinical investigation in patients with solid tumors.